Peripheral Artery Disease: Mercator MedSystems Wins CE Mark for Catheter Systems
Privately-held medical device company Mercator MedSystems touts regulatory wins in the EU for a pair of micro-infusion catheters for trating peripheral artery disease.
Mercator MedSystems touted European regulatory approvals for a pair of micro-infusion catheters for the treatment of peripheral artery disease.
The San Leandro, Calif.-based medical device company received CE Mark approval in the European Union to market its Cricket and Bullfrog catheters, which are designed to inject therapeutic agents safely through blood vessel walls into deep tissues. The pair of products already have FDA clearance for the U.S. market.